December 9, 2021 |
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549
RE: | BiomX Inc. | |
Registration Statement on Form S-3 | ||
File No. 333-261419 |
Dear Sir or Madam:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, BiomX Inc. (the “Registrant”) hereby requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time, on December 13, 2021, or as soon as practicable thereafter.
The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Howard E. Berkenblit of Sullivan & Worcester LLP at (617) 338-2979 and that such effectiveness also be confirmed in writing.
[Signature page follows]
United States Securities and Exchange Commission
December 9, 2021
Page 2
Very truly yours, | |||
BiomX Inc. | |||
By: | /s/ Marina Wolfson | ||
Name: | Marina Wolfson | ||
Title: | Senior Vice President for Finance and Operations |
Signature Page to Acceleration Request